{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:26:22Z","timestamp":1791861982341,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Commission of Nanjing","award":["201803001"],"award-info":[{"award-number":["201803001"]}]},{"name":"Medical Science and Technology Development Foundation, Nanjing Department of Health","award":["YKK17167"],"award-info":[{"award-number":["YKK17167"]}]},{"name":"Medical Science and Technology Development Foundation, Nanjing Department of Health","award":["YKK21119"],"award-info":[{"award-number":["YKK21119"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Leukocyte immunoglobulin-like receptor subfamily B (LILRB), including 5 subtypes, is a group of inhibitory receptors in the immune system. The LILRB family is known to be involved in the tumor progression of various cancer types, especially liver cancer. However, the expression patterns and prognostic values of LILRB family members in liver cancer tissues remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the Oncomine database, GEPIA database, Kaplan\u2013Meier Plotter, Timer, and TISIDB to assess the expression and prognostic value of the LILRB family in liver cancer patients. We also verified the expression of the LILRB family in tumor tissues and tumor-free liver tissues at the protein level by using immunohistochemistry. The STRING website was used to explore the interaction between the LILRB family and their related genes. The DAVID database was used to perform the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Flow cytometry was used to assess the infiltrated NK cells in liver cancer tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our study revealed that the mRNA expression of LILRB1, LILRB2, LILRB3, and LILRB5 was downregulated, while compared with normal tissues, the mRNA expression of LILRB4 was upregulated in liver cancer tissues. Survival analysis revealed that LILRB2 and LILRB5 mRNA expression levels were significantly positively associated with overall survival (OS) and disease-free survival (DSS) and that the mRNA expression of all LILRB family members was significantly positively correlated with recurrence-free survival (RFS) and progression-free survival (PFS). Next, we further found that the mRNA expression of all LILRB family members was significantly associated with the infiltration of B cells, CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, macrophages, neutrophils, and dendritic cells in liver cancer. Finally, GO and KEGG analyses found that the LILRB family and its related genes were involved in antigen processing and presentation and natural killer cell-mediated cytotoxicity pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study suggested that LILRB family expression was associated with the prognosis of liver cancer patients and infiltrated immune cells. The LILRB family might be involved in antigen processing and presentation and natural killer cell-mediated cytotoxicity pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-022-02562-w","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T06:25:53Z","timestamp":1648189553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Jing","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangnan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-1212","authenticated-orcid":false,"given":"Yongxiang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"issue":"6","key":"2562_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA: A Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA: A Cancer J Clin"},{"issue":"4","key":"2562_CR2","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.7314\/APJCP.2016.17.4.2041","volume":"17","author":"M Mohammadian","year":"2016","unstructured":"Mohammadian M, Soroush A, Mohammadian-Hafshejani A, et al. Incidence and mortality of liver cancer and their relationship with development in Asia [J]. Asian Pacific J Cancer Prev. 2016;17(4):2041\u20137.","journal-title":"Asian Pacific J Cancer Prev"},{"issue":"1","key":"2562_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1186\/s12885-018-4695-9","volume":"18","author":"D Mak","year":"2018","unstructured":"Mak D, Sengayi M, Chen WC, et al. Liver cancer mortality trends in South Africa: 1999\u20132015[J]. BMC Cancer. 2018;18(1):798.","journal-title":"BMC Cancer"},{"issue":"1","key":"2562_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","volume":"39","author":"R-M Feng","year":"2019","unstructured":"Feng R-M, Zong Y-N, Cao S-M, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun. 2019;39(1):22.","journal-title":"Cancer Commun"},{"issue":"3","key":"2562_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000488035","volume":"7","author":"J Zhou","year":"2018","unstructured":"Zhou J, Sun H-C, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition)[J]. Liver Cancer. 2018;7(3):235\u201360.","journal-title":"Liver Cancer"},{"issue":"5","key":"2562_CR6","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.4049\/jimmunol.1003078","volume":"186","author":"DC Jones","year":"2011","unstructured":"Jones DC, Kosmoliaptsis V, Apps R, et al. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding [J]. J Immunol. 2011;186(5):2990.","journal-title":"J Immunol"},{"key":"2562_CR7","doi-asserted-by":"crossref","unstructured":"Wang L,\u00a0Fan J,\u00a0Ye W,\u00a0Han J,\u00a0Zhang Y,\u00a0Zhao L,\u00a0Duan J,\u00a0Yin D,\u00a0Yi Y.\u00a0\u00a0The expression of ILT4 in myeloid dendritic cells in patients with hepatocellular carcinoma.\u00a0Immunol Invest.\u00a02019;48(7):704\u201318.","DOI":"10.1080\/08820139.2019.1571507"},{"issue":"3","key":"2562_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.4049\/jimmunol.1501937","volume":"196","author":"DN Burshtyn","year":"2016","unstructured":"Burshtyn DN, Morcos C. The expanding spectrum of ligands for leukocyte Ig-like receptors [J]. J Immunol. 2016;196(3):947.","journal-title":"J Immunol"},{"issue":"6","key":"2562_CR9","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1182\/blood-2007-05-089771","volume":"111","author":"NT Young","year":"2008","unstructured":"Young NT, Waller ECP, Patel R, et al. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells [J]. Blood. 2008;111(6):3090\u20136.","journal-title":"Blood"},{"issue":"2","key":"2562_CR10","doi-asserted-by":"publisher","first-page":"e000515","DOI":"10.1136\/jitc-2019-000515","volume":"8","author":"H Chen","year":"2020","unstructured":"Chen H, Chen Y, Deng M, et al. Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells [J]. J Immunother Cancer. 2020;8(2):e000515.","journal-title":"J Immunother Cancer"},{"key":"2562_CR11","doi-asserted-by":"crossref","unstructured":"Jones DC,\u00a0Hewitt CRA,\u00a0L\u00f3pez-\u00c1lvarez MR,\u00a0Jahnke M,\u00a0Russell AI,\u00a0Radjabova V,\u00a0Trowsdale ARZ,\u00a0Trowsdale J. Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells.\u00a0Oncotarget. 2016;7(13):15618.","DOI":"10.18632\/oncotarget.6905"},{"issue":"1","key":"2562_CR12","doi-asserted-by":"publisher","first-page":"21780","DOI":"10.1038\/srep21780","volume":"6","author":"LE Hogan","year":"2016","unstructured":"Hogan LE, Jones DC, Allen RL. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure [J]. Sci Rep. 2016;6(1):21780.","journal-title":"Sci Rep"},{"issue":"18","key":"2562_CR13","doi-asserted-by":"publisher","first-page":"e141593","DOI":"10.1172\/jci.insight.141593","volume":"5","author":"M Yeboah","year":"2020","unstructured":"Yeboah M, Papagregoriou C, Jones DC, et al. LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation [J]. JCI Insight. 2020;5(18):e141593.","journal-title":"JCI Insight"},{"issue":"1","key":"2562_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/15384101.2015.1121324","volume":"15","author":"X Kang","year":"2016","unstructured":"Kang X, Kim J, Deng M, et al. Inhibitory leukocyte immunoglobulin-like receptors: immune checkpoint proteins and tumor sustaining factors [J]. Cell Cycle. 2016;15(1):25\u201340.","journal-title":"Cell Cycle"},{"issue":"6","key":"2562_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/tan.12561","volume":"85","author":"A Wi\u015bniewski","year":"2015","unstructured":"Wi\u015bniewski A, Kowal A, Wyrodek E, et al. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer [J]. Tissue Antigens. 2015;85(6):466\u201375.","journal-title":"Tissue Antigens"},{"key":"2562_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/CBM-190940","volume":"28","author":"J Cheng","year":"2020","unstructured":"Cheng J, Luan J, Chen P, et al. Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1[J]. Cancer Biomarkers. 2020;28:309\u201319.","journal-title":"Cancer Biomarkers"},{"issue":"25","key":"2562_CR17","doi-asserted-by":"publisher","first-page":"21004","DOI":"10.18632\/oncotarget.4217","volume":"6","author":"X Liu","year":"2015","unstructured":"Liu X, Yu X, Xie J, et al. ANGPTL2\/LILRB2 signaling promotes the propagation of lung cancer cells [J]. Oncotarget. 2015;6(25):21004\u201315.","journal-title":"Oncotarget"},{"issue":"15","key":"2562_CR18","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.18632\/oncotarget.3624","volume":"6","author":"P Zhang","year":"2015","unstructured":"Zhang P, Guo X, Li J, et al. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer [J]. Oncotarget. 2015;6(15):13550\u201363.","journal-title":"Oncotarget"},{"issue":"10","key":"2562_CR19","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.ymthe.2018.08.001","volume":"26","author":"S John","year":"2018","unstructured":"John S, Chen H, Deng M, et al. A novel anti-LILRB4 CAR-T cell for the treatment of monocytic AML [J]. Mole Therapy. 2018;26(10):2487\u201395.","journal-title":"Mole Therapy"},{"issue":"W1","key":"2562_CR20","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses [J]. Nucleic Acids Res. 2017;45(W1):W98\u2013W102.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2562_CR21","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","volume":"8","author":"LA Nagy","year":"2018","unstructured":"Nagy LA, Menyh\u00e1rt O, et al. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets [J]. Sci Rep. 2018;8(1):9227.","journal-title":"Sci Rep"},{"issue":"21","key":"2562_CR22","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells [J]. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"20","key":"2562_CR23","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor\u2013immune system interactions [J]. Bioinformatics. 2019;35(20):4200\u20132.","journal-title":"Bioinformatics"},{"issue":"D1","key":"2562_CR24","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2018","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets [J]. Nucleic Acids Res. 2018;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2562_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J]. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"1","key":"2562_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1470-2045(11)70318-7","volume":"13","author":"R Pirker","year":"2012","unstructured":"Pirker R, Pereira JR, Von Pawel J, et al. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study [J]. Lancet Oncol. 2012;13(1):33\u201342.","journal-title":"Lancet Oncol"},{"issue":"4","key":"2562_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep.21622","volume":"45","author":"E Wurmbach","year":"2007","unstructured":"Wurmbach E, Chen Y-B, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma [J]. Hepatology. 2007;45(4):938\u201347.","journal-title":"Hepatology"},{"issue":"24","key":"2562_CR28","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler S, Jia H-L, Budhu A, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients [J]. Cancer Res. 2010;70(24):10202.","journal-title":"Cancer Res"},{"issue":"3-4","key":"2562_CR29","first-page":"85","volume":"15","author":"VR Mas","year":"2009","unstructured":"Mas VR, Maluf DG, Archer KJ, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma [J]. Mole Med (Cambridge, Mass.). 2009;15(3-4):85\u201394.","journal-title":"Mole Med (Cambridge, Mass.)"},{"issue":"6","key":"2562_CR30","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023","volume":"13","author":"X Chen","year":"2002","unstructured":"Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers [J]. Mole Biol Cell. 2002;13(6):1929\u201339.","journal-title":"Mole Biol Cell"},{"issue":"1","key":"2562_CR31","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1038\/s41598-017-08128-1","volume":"7","author":"W Yao","year":"2017","unstructured":"Yao W, He J-C, Yang Y, et al. The prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: a systematic review and meta-analysis [J]. Sci Rep. 2017;7(1):7525.","journal-title":"Sci Rep"},{"issue":"8","key":"2562_CR32","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.4049\/jimmunol.170.8.4095","volume":"170","author":"X Gu","year":"2003","unstructured":"Gu X, Laouar A, Wan J, et al. The gp49B1 inhibitory receptor regulates the IFN-\u03b3 responses of T cells and NK cells [J]. J Immunol. 2003;170(8):4095.","journal-title":"J Immunol"},{"issue":"5","key":"2562_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.transproceed.2011.10.056","volume":"44","author":"YQ Si","year":"2012","unstructured":"Si YQ, Bian XK, Lu N, et al. Cyclosporine induces up-regulation of immunoglobulin-like transcripts 3 and 4 expression on and activity of NKL cells [J]. Transplant Proc. 2012;44(5):1407\u201311.","journal-title":"Transplant Proc"},{"issue":"5","key":"2562_CR34","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.3892\/mmr.2017.7581","volume":"16","author":"Z Jin","year":"2017","unstructured":"Jin Z, Fan J, Zhang Y, et al. Comparison of morphology, phenotypes and function between cultured human IL4DC and IFNDC [J]. Mol Med Rep. 2017;16(5):7345\u201354.","journal-title":"Mol Med Rep"},{"key":"2562_CR35","doi-asserted-by":"crossref","unstructured":"Vujanovic L, Chuckran C, Lin Y,\u00a0Ding F,\u00a0Sander CA,\u00a0Santos PM,\u00a0Lohr J,\u00a0Mashadi-Hossein A,\u00a0Warren S,\u00a0White A.\u00a0CD56dim CD16\u2212 natural killer cell profiling in melanoma patients receiving a cancer vaccine and interferon-\u03b1. Front Immunol. 2019;10:14.","DOI":"10.3389\/fimmu.2019.00014"},{"issue":"1","key":"2562_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","volume":"19","author":"AA Barkal","year":"2018","unstructured":"Barkal AA, Weiskopf K, Kao KS, et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy [J]. Nat Immunol. 2018;19(1):76\u201384.","journal-title":"Nat Immunol"},{"key":"2562_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40364-020-00191-7","volume":"8","author":"Q Li","year":"2020","unstructured":"Li Q, Li J, Wang S, et al. Overexpressed immunoglobulin-like transcript (ILT) 4 in lung adenocarcinoma is correlated with immunosuppressive T cell subset infiltration and poor patient outcomes [J]. Biomarker Res. 2020;8:11.","journal-title":"Biomarker Res"},{"issue":"7","key":"2562_CR38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.4103\/jcrt.JCRT_542_18","volume":"14","author":"X Li","year":"2018","unstructured":"Li X, Wei X, Xu H, et al. Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance [J]. J Cancer Res Therapeut. 2018;14(7):1655\u20139.","journal-title":"J Cancer Res Therapeut"},{"issue":"4","key":"2562_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN. T cell dysfunction in cancer [J]. Cancer cell. 2018;33(4):547\u201362.","journal-title":"Cancer cell"},{"issue":"38","key":"2562_CR40","doi-asserted-by":"publisher","first-page":"14515","DOI":"10.1073\/pnas.0804571105","volume":"105","author":"S Endo","year":"2008","unstructured":"Endo S, Sakamoto Y, Kobayashi E, et al. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells [J]. Proc National Acad Sci. 2008;105(38):14515\u201320.","journal-title":"Proc National Acad Sci"},{"issue":"12","key":"2562_CR41","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1172\/JCI97570","volume":"128","author":"H-M Chen","year":"2018","unstructured":"Chen H-M, Van Der Touw W, Wang YS, et al. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity [J]. J Clin Invest. 2018;128(12):5647\u201362.","journal-title":"J Clin Invest"},{"issue":"3","key":"2562_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.23054","volume":"50","author":"B Hoechst","year":"2009","unstructured":"Hoechst B, Voigtlaender T, Ormandy L, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor [J]. Hepatology. 2009;50(3):799\u2013807.","journal-title":"Hepatology"},{"key":"2562_CR43","doi-asserted-by":"crossref","unstructured":"Amand M, Iserentant G, Poli A,\u00a0Sleiman M,\u00a0Fievez V,\u00a0Sanchez IP,\u00a0Sauvageot N,\u00a0Michel T,\u00a0Aouali N,\u00a0Janji B.\u00a0Human CD56dimCD16dim cells as an individualized natural killer cell subset. Front Immunol. 2017;8:699.","DOI":"10.3389\/fimmu.2017.00699"},{"issue":"3","key":"2562_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","volume":"129","author":"L Cai","year":"2008","unstructured":"Cai L, Zhang Z, Zhou L, et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients [J]. Clin Immunol. 2008;129(3):428\u201337.","journal-title":"Clin Immunol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02562-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02562-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02562-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T06:26:37Z","timestamp":1648189597000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02562-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2562"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02562-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-752285\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-752285\/v2","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethical committee of the Second Hospital of Nanjing, Nanjing University of Chinese Medicine. Written informed consent was obtained from all donors in accordance with the Declaration of Helsinki (1964) before tissue sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}